Novartis declares HSR waiting period for Regulus Therapeutics tender offer has ended

Regulus Therapeutics Inc. recently announced that it has received a non-binding acquisition proposal from an unnamed party. The proposal suggests acquiring all outstanding shares of Regulus for $0.24 per share in cash. This represents a significant premium of over 300% to Regulus’ closing stock price on the last trading day before the proposal was made.

The Regulus Board of Directors is currently reviewing the proposed acquisition and has not made any decisions regarding the offer. The company has advised its shareholders not to take any action or make any decisions until the Board has completed its review and evaluation of the proposal.

Regulus also disclosed that it is in talks with the potential acquirer to further discuss and negotiate the terms of the acquisition. The company emphasized that there is no guarantee that these discussions will lead to a definitive agreement.

The proposed acquisition comes at a time when Regulus is facing challenges and uncertainties in its business operations. The company has been experiencing financial difficulties and has been exploring strategic alternatives to enhance shareholder value. The acquisition offer may provide an opportunity for Regulus to address its financial struggles and potentially unlock value for its shareholders.

Investors and analysts are closely monitoring the developments surrounding the proposed acquisition of Regulus. The outcome of the Board’s review and negotiations with the potential acquirer will play a significant role in determining the future direction of the company.

In response to the acquisition proposal, shares of Regulus saw a sharp increase in trading volume and a significant rise in stock price. This indicates that investors are optimistic about the potential acquisition and its impact on the company’s financial prospects.

It is essential for shareholders to exercise caution and carefully consider the implications of the proposed acquisition before making any decisions. The Board of Directors of Regulus will continue to keep shareholders informed of any material developments related to the acquisition proposal.

Overall, the proposed acquisition of Regulus represents a significant opportunity for the company to address its financial challenges and create value for its shareholders. The outcome of the ongoing discussions and negotiations will determine the future path of Regulus and its stakeholders.